Galectin Therapeutics (GALT) Research & Development (2010 - 2026)
Galectin Therapeutics (GALT) recorded Research & Development of $2.14 million in Q2 2026, down 34.5% from $3.26 million a year earlier and down 4.3% from the prior quarter.
Powered by 
Analysis
Galectin Therapeutics (GALT) Research & Development (2010 - 2026) Analysis & Trends
On a TTM basis, Galectin Therapeutics' Research & Development came in at $8.91 million as of Jun 30, 2026, down 68.7% year-over-year; for FY2025, it was $14.29 million, down 60.9% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of -4.5% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $36.57 million in FY2024 (+13.8%), $32.13 million in FY2023 (+1.2%), $31.74 million in FY2022 (+33.2%) and $23.82 million in FY2021 (+32.5%).
- Quarterly Research & Development has ranged from $1.93 million in Q4 2025 to $11.11 million in Q4 2024 over the past five years.
- On a year-over-year basis, Research & Development has declined for six consecutive quarters, with an average decline of 37.7% over the last eight quarters.
- Peak year-over-year performance for Research & Development in the last five years was growth of 64.5% in Q1 2022, against a decline of 82.6% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.23 million (Q1 2026), $1.93 million (Q4 2025) and $2.61 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Galectin Therapeutics | 260.61 Mn | 260.61 Mn | - | 2.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.14 Mn |
| Mar 31, 2026 | 2.23 Mn |
| Dec 31, 2025 | 1.93 Mn |
| Sep 30, 2025 | 2.61 Mn |
| Jun 30, 2025 | 3.26 Mn |
| Mar 31, 2025 | 6.49 Mn |
| Dec 31, 2024 | 11.11 Mn |
| Sep 30, 2024 | 7.60 Mn |
| Jun 30, 2024 | 9.81 Mn |
| Mar 31, 2024 | 8.05 Mn |
| Dec 31, 2023 | 8.23 Mn |
| Sep 30, 2023 | 7.73 Mn |
| Jun 30, 2023 | 7.37 Mn |
| Mar 31, 2023 | 8.80 Mn |
| Dec 31, 2022 | 9.01 Mn |
| Sep 30, 2022 | 6.60 Mn |
| Jun 30, 2022 | 8.07 Mn |
| Mar 31, 2022 | 8.06 Mn |
| Dec 31, 2021 | 5.86 Mn |
| Sep 30, 2021 | 6.61 Mn |
API Access
Galectin Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();